Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Hodgkin Disease 65Lymphoma 39Lymphoma, Large-Cell, Anaplastic 4Recurrence 3Leukemia 2HIV Infections 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Hematologic Diseases 1Dendritic Cell Sarcoma, Interdigitating 1Acquired Immunodeficiency Syndrome 1AIDS-Related Complex 1

Interventions

Cyclophosphamide 12Vincristine 10Doxorubicin 10Etoposide 8Rituximab 6Prednisone 6Cytarabine 6Dexamethasone 5Bleomycin 5Zidovudine 4Methotrexate 4Leucovorin 4Filgrastim 4Peripheral Blood Stem Cell Transplantation 3sargramostim 2fludarabine phosphate 2fludarabine 2Whole-Body Irradiation 2Vinblastine 2Polymerase Chain Reaction 2Melphalan 2Dacarbazine 2Carmustine 2Antiretroviral Therapy, Highly Active 2Allopurinol 2prednylidene 1pembrolizumab 1liposomal doxorubicin 1ibrutinib 1efavirenz 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
HIV Infections × Vinblastine × Lymphoid × Clear all
NCT00822120 2022-08-18

S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma

SWOG Cancer Research Network

Phase 2 Completed
371 enrolled 14 charts
Lymphoid

Hodgkin Disease, Lymphoma, HIV Infections

NCT00000626 2021-10-27

Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Completed
27 enrolled
Lymphoid

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Hodgkin Disease, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡